Jefferies Maintains Buy on RXO, Lowers Price Target to $31
Portfolio Pulse from Benzinga Newsdesk
Jefferies analyst Stephanie Moore maintains a Buy rating on RXO (NYSE:RXO) but lowers the price target from $33 to $31.
August 13, 2024 | 5:24 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Jefferies analyst Stephanie Moore maintains a Buy rating on RXO but lowers the price target from $33 to $31.
The Buy rating suggests continued confidence in RXO's performance, but the lowered price target indicates some caution. This mixed signal is likely to result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100